Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Glucagon Drug Market Growth 2022-2028

  • LP 4759624
  • 70 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Glucagon Drug will have significant change from previous year. According to our (LP Information) latest study, the global Glucagon Drug market size is USD million in 2022 from USD 543.9 million in 2021, with a change of % between 2021 and 2022. The global Glucagon Drug market size will reach USD 828.9 million in 2028, growing at a CAGR of 6.2% over the analysis period.

The United States Glucagon Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Glucagon Drug market, reaching US$ million by the year 2028. As for the Europe Glucagon Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Glucagon Drug players cover Novo Nordisk, Eli Lilly, Fresenius Kabi, and Torrent Labs, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Glucagon Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Inject Glucagon

Nasal Glucagon

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Emergency Kits

General Use

Diagnostic & Motility

Cardiogenic Shock

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Novo Nordisk

Eli Lilly

Fresenius Kabi

Torrent Labs

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Glucagon Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Glucagon Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Glucagon Drug by Country/Region, 2017, 2022 & 2028

2.2 Glucagon Drug Segment by Type

2.2.1 Inject Glucagon

2.2.2 Nasal Glucagon

2.3 Glucagon Drug Sales by Type

2.3.1 Global Glucagon Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Glucagon Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Glucagon Drug Sale Price by Type (2017-2022)

2.4 Glucagon Drug Segment by Application

2.4.1 Emergency Kits

2.4.2 General Use

2.4.3 Diagnostic & Motility

2.4.4 Cardiogenic Shock

2.4.5 Others

2.5 Glucagon Drug Sales by Application

2.5.1 Global Glucagon Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Glucagon Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Glucagon Drug Sale Price by Application (2017-2022)

3 Global Glucagon Drug by Company

3.1 Global Glucagon Drug Breakdown Data by Company

3.1.1 Global Glucagon Drug Annual Sales by Company (2020-2022)

3.1.2 Global Glucagon Drug Sales Market Share by Company (2020-2022)

3.2 Global Glucagon Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Glucagon Drug Revenue by Company (2020-2022)

3.2.2 Global Glucagon Drug Revenue Market Share by Company (2020-2022)

3.3 Global Glucagon Drug Sale Price by Company

3.4 Key Manufacturers Glucagon Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Glucagon Drug Product Location Distribution

3.4.2 Players Glucagon Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Glucagon Drug by Geographic Region

4.1 World Historic Glucagon Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Glucagon Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Glucagon Drug Annual Revenue by Geographic Region

4.2 World Historic Glucagon Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Glucagon Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Glucagon Drug Annual Revenue by Country/Region

4.3 Americas Glucagon Drug Sales Growth

4.4 APAC Glucagon Drug Sales Growth

4.5 Europe Glucagon Drug Sales Growth

4.6 Middle East & Africa Glucagon Drug Sales Growth

5 Americas

5.1 Americas Glucagon Drug Sales by Country

5.1.1 Americas Glucagon Drug Sales by Country (2017-2022)

5.1.2 Americas Glucagon Drug Revenue by Country (2017-2022)

5.2 Americas Glucagon Drug Sales by Type

5.3 Americas Glucagon Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Glucagon Drug Sales by Region

6.1.1 APAC Glucagon Drug Sales by Region (2017-2022)

6.1.2 APAC Glucagon Drug Revenue by Region (2017-2022)

6.2 APAC Glucagon Drug Sales by Type

6.3 APAC Glucagon Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Glucagon Drug by Country

7.1.1 Europe Glucagon Drug Sales by Country (2017-2022)

7.1.2 Europe Glucagon Drug Revenue by Country (2017-2022)

7.2 Europe Glucagon Drug Sales by Type

7.3 Europe Glucagon Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Glucagon Drug by Country

8.1.1 Middle East & Africa Glucagon Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Glucagon Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Glucagon Drug Sales by Type

8.3 Middle East & Africa Glucagon Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Glucagon Drug

10.3 Manufacturing Process Analysis of Glucagon Drug

10.4 Industry Chain Structure of Glucagon Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Glucagon Drug Distributors

11.3 Glucagon Drug Customer

12 World Forecast Review for Glucagon Drug by Geographic Region

12.1 Global Glucagon Drug Market Size Forecast by Region

12.1.1 Global Glucagon Drug Forecast by Region (2023-2028)

12.1.2 Global Glucagon Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Glucagon Drug Forecast by Type

12.7 Global Glucagon Drug Forecast by Application

13 Key Players Analysis

13.1 Novo Nordisk

13.1.1 Novo Nordisk Company Information

13.1.2 Novo Nordisk Glucagon Drug Product Offered

13.1.3 Novo Nordisk Glucagon Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novo Nordisk Main Business Overview

13.1.5 Novo Nordisk Latest Developments

13.2 Eli Lilly

13.2.1 Eli Lilly Company Information

13.2.2 Eli Lilly Glucagon Drug Product Offered

13.2.3 Eli Lilly Glucagon Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Eli Lilly Main Business Overview

13.2.5 Eli Lilly Latest Developments

13.3 Fresenius Kabi

13.3.1 Fresenius Kabi Company Information

13.3.2 Fresenius Kabi Glucagon Drug Product Offered

13.3.3 Fresenius Kabi Glucagon Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Fresenius Kabi Main Business Overview

13.3.5 Fresenius Kabi Latest Developments

13.4 Torrent Labs

13.4.1 Torrent Labs Company Information

13.4.2 Torrent Labs Glucagon Drug Product Offered

13.4.3 Torrent Labs Glucagon Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Torrent Labs Main Business Overview

13.4.5 Torrent Labs Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Glucagon Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Glucagon Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Inject Glucagon

Table 4. Major Players of Nasal Glucagon

Table 5. Global Glucagon Drug Sales by Type (2017-2022) & (K Units)

Table 6. Global Glucagon Drug Sales Market Share by Type (2017-2022)

Table 7. Global Glucagon Drug Revenue by Type (2017-2022) & ($ million)

Table 8. Global Glucagon Drug Revenue Market Share by Type (2017-2022)

Table 9. Global Glucagon Drug Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Glucagon Drug Sales by Application (2017-2022) & (K Units)

Table 11. Global Glucagon Drug Sales Market Share by Application (2017-2022)

Table 12. Global Glucagon Drug Revenue by Application (2017-2022)

Table 13. Global Glucagon Drug Revenue Market Share by Application (2017-2022)

Table 14. Global Glucagon Drug Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Glucagon Drug Sales by Company (2020-2022) & (K Units)

Table 16. Global Glucagon Drug Sales Market Share by Company (2020-2022)

Table 17. Global Glucagon Drug Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Glucagon Drug Revenue Market Share by Company (2020-2022)

Table 19. Global Glucagon Drug Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Glucagon Drug Producing Area Distribution and Sales Area

Table 21. Players Glucagon Drug Products Offered

Table 22. Glucagon Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Glucagon Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Glucagon Drug Sales Market Share Geographic Region (2017-2022)

Table 27. Global Glucagon Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Glucagon Drug Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Glucagon Drug Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Glucagon Drug Sales Market Share by Country/Region (2017-2022)

Table 31. Global Glucagon Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Glucagon Drug Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Glucagon Drug Sales by Country (2017-2022) & (K Units)

Table 34. Americas Glucagon Drug Sales Market Share by Country (2017-2022)

Table 35. Americas Glucagon Drug Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Glucagon Drug Revenue Market Share by Country (2017-2022)

Table 37. Americas Glucagon Drug Sales by Type (2017-2022) & (K Units)

Table 38. Americas Glucagon Drug Sales Market Share by Type (2017-2022)

Table 39. Americas Glucagon Drug Sales by Application (2017-2022) & (K Units)

Table 40. Americas Glucagon Drug Sales Market Share by Application (2017-2022)

Table 41. APAC Glucagon Drug Sales by Region (2017-2022) & (K Units)

Table 42. APAC Glucagon Drug Sales Market Share by Region (2017-2022)

Table 43. APAC Glucagon Drug Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Glucagon Drug Revenue Market Share by Region (2017-2022)

Table 45. APAC Glucagon Drug Sales by Type (2017-2022) & (K Units)

Table 46. APAC Glucagon Drug Sales Market Share by Type (2017-2022)

Table 47. APAC Glucagon Drug Sales by Application (2017-2022) & (K Units)

Table 48. APAC Glucagon Drug Sales Market Share by Application (2017-2022)

Table 49. Europe Glucagon Drug Sales by Country (2017-2022) & (K Units)

Table 50. Europe Glucagon Drug Sales Market Share by Country (2017-2022)

Table 51. Europe Glucagon Drug Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Glucagon Drug Revenue Market Share by Country (2017-2022)

Table 53. Europe Glucagon Drug Sales by Type (2017-2022) & (K Units)

Table 54. Europe Glucagon Drug Sales Market Share by Type (2017-2022)

Table 55. Europe Glucagon Drug Sales by Application (2017-2022) & (K Units)

Table 56. Europe Glucagon Drug Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Glucagon Drug Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Glucagon Drug Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Glucagon Drug Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Glucagon Drug Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Glucagon Drug Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Glucagon Drug Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Glucagon Drug Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Glucagon Drug Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Glucagon Drug

Table 66. Key Market Challenges & Risks of Glucagon Drug

Table 67. Key Industry Trends of Glucagon Drug

Table 68. Glucagon Drug Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Glucagon Drug Distributors List

Table 71. Glucagon Drug Customer List

Table 72. Global Glucagon Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Glucagon Drug Sales Market Forecast by Region

Table 74. Global Glucagon Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Glucagon Drug Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Glucagon Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Glucagon Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Glucagon Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Glucagon Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Glucagon Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Glucagon Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Glucagon Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Glucagon Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Glucagon Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Glucagon Drug Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Glucagon Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Glucagon Drug Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Glucagon Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Glucagon Drug Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Glucagon Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Glucagon Drug Revenue Market Share Forecast by Application (2023-2028)

Table 92. Novo Nordisk Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors

Table 93. Novo Nordisk Glucagon Drug Product Offered

Table 94. Novo Nordisk Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Novo Nordisk Main Business

Table 96. Novo Nordisk Latest Developments

Table 97. Eli Lilly Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors

Table 98. Eli Lilly Glucagon Drug Product Offered

Table 99. Eli Lilly Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Eli Lilly Main Business

Table 101. Eli Lilly Latest Developments

Table 102. Fresenius Kabi Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors

Table 103. Fresenius Kabi Glucagon Drug Product Offered

Table 104. Fresenius Kabi Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Fresenius Kabi Main Business

Table 106. Fresenius Kabi Latest Developments

Table 107. Torrent Labs Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors

Table 108. Torrent Labs Glucagon Drug Product Offered

Table 109. Torrent Labs Glucagon Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Torrent Labs Main Business

Table 111. Torrent Labs Latest Developments

List of Figures

Figure 1. Picture of Glucagon Drug

Figure 2. Glucagon Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Glucagon Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Glucagon Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Glucagon Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Inject Glucagon

Figure 10. Product Picture of Nasal Glucagon

Figure 11. Global Glucagon Drug Sales Market Share by Type in 2021

Figure 12. Global Glucagon Drug Revenue Market Share by Type (2017-2022)

Figure 13. Glucagon Drug Consumed in Emergency Kits

Figure 14. Global Glucagon Drug Market: Emergency Kits (2017-2022) & (K Units)

Figure 15. Glucagon Drug Consumed in General Use

Figure 16. Global Glucagon Drug Market: General Use (2017-2022) & (K Units)

Figure 17. Glucagon Drug Consumed in Diagnostic & Motility

Figure 18. Global Glucagon Drug Market: Diagnostic & Motility (2017-2022) & (K Units)

Figure 19. Glucagon Drug Consumed in Cardiogenic Shock

Figure 20. Global Glucagon Drug Market: Cardiogenic Shock (2017-2022) & (K Units)

Figure 21. Glucagon Drug Consumed in Others

Figure 22. Global Glucagon Drug Market: Others (2017-2022) & (K Units)

Figure 23. Global Glucagon Drug Sales Market Share by Application (2017-2022)

Figure 24. Global Glucagon Drug Revenue Market Share by Application in 2021

Figure 25. Glucagon Drug Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Glucagon Drug Revenue Market Share by Company in 2021

Figure 27. Global Glucagon Drug Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Glucagon Drug Revenue Market Share by Geographic Region in 2021

Figure 29. Global Glucagon Drug Sales Market Share by Region (2017-2022)

Figure 30. Global Glucagon Drug Revenue Market Share by Country/Region in 2021

Figure 31. Americas Glucagon Drug Sales 2017-2022 (K Units)

Figure 32. Americas Glucagon Drug Revenue 2017-2022 ($ Millions)

Figure 33. APAC Glucagon Drug Sales 2017-2022 (K Units)

Figure 34. APAC Glucagon Drug Revenue 2017-2022 ($ Millions)

Figure 35. Europe Glucagon Drug Sales 2017-2022 (K Units)

Figure 36. Europe Glucagon Drug Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Glucagon Drug Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Glucagon Drug Revenue 2017-2022 ($ Millions)

Figure 39. Americas Glucagon Drug Sales Market Share by Country in 2021

Figure 40. Americas Glucagon Drug Revenue Market Share by Country in 2021

Figure 41. United States Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Glucagon Drug Sales Market Share by Region in 2021

Figure 46. APAC Glucagon Drug Revenue Market Share by Regions in 2021

Figure 47. China Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Glucagon Drug Sales Market Share by Country in 2021

Figure 54. Europe Glucagon Drug Revenue Market Share by Country in 2021

Figure 55. Germany Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Glucagon Drug Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Glucagon Drug Revenue Market Share by Country in 2021

Figure 62. Egypt Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Glucagon Drug Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Glucagon Drug in 2021

Figure 68. Manufacturing Process Analysis of Glucagon Drug

Figure 69. Industry Chain Structure of Glucagon Drug

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390